Uveitis: Pediatric Patients Did Fine on Adalimumab
November 28th 2016Adalimumab has the potential to serve an important role in management of chronic and refractory noninfectious uveitis and associated macular edema with low rates of serious adverse events in the long term, according to a recent report. That includes pediatric patients.
Read More
Stroke: Early Doses of Novel Anticoagulants Pose No Additional Hemorrhage Risk
October 10th 2016After an ischemic stroke, oral anti-coagulants reduce the risk of recurrence, but does giving these drugs early increase the risk of intracranial bleeding? A study found such early dosing does not appear to add to the chances of such a hemorrhage.
Read More